Utang jangka cendhak marang modal: Utah Medical Products Inc. (UTMD)

Logo korporat perusahaan Utah Medical Products (UTMD)

Utah Medical Products is expanding its presence in global B2B markets through new gynecology products while simultaneously implementing energy-saving technologies and plastic recycling to reduce environmental impact. This chart illustrating the market price movement for the individual debt-to-equity metric shows 0.00. The business relies on global exports, which remain a safe haven from trade conflicts and political restrictions.

UTMD - Koefisien utang jangka cendhak marang modal Utah Medical Products Inc. ing rentang 04.07.2022 - 31.10.2026
Produk merek Utah Medical Products, Inc.

This ratio compares short-term liabilities to net assets, determining the liquid margin of safety and the degree of dependence on borrowed capital. The metric's dynamics allow an investor to assess default risk or financial leverage efficiency prior to the publication of reports. Analysis of the short-term debt-to-equity ratio reveals the balance between stability and expansion. For Utah Medical Products (UTMD), this is critical when undergoing FDA audits to scale its niche equipment ecosystem.

Pesaing langsung

Utang jangka cendhak marang modal ISRG|DHR - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal BDX (Becton Dickinson & Co)|STE: Rasio utang jangka cendhak marang modal|West Pharmaceutical Services, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Baxter International Inc. BAX|MASI: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Stevanato Group Corp|TFX (Teleflex Incorporated) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal merit.com|Utang jangka cendhak marang ekuitas Envista (NVST)|Utang jangka cendhak marang ekuitas ICUI (ICU Medical Inc)|Dentsply - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal LMAT|AtriCure, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal staar.com STAA|Niagen (NAGE) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal ZIMV|Utang jangka cendhak marang ekuitas AngioDynamics Corp|Cerus Inc (CERS) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas TKNO (Alpha Teknova, Inc.)|Rasio silihan jangka cendhak marang modal MGRM|Utang jangka cendhak marang ekuitas Sharps Technology STSS|Rasio tanggungan utang jangka cendhak marang modal INFU|KRMD: Rasio utang jangka cendhak marang ekuitas|NYXH - Utang jangka cendhak marang modal|Microbot Medical Inc. (MBOT) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas pro-dex.com|ZTEK (Zentek) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Elutia Inc ELUT|Utang jangka cendhak marang ekuitas Milestone Scientific Corp (MLSS)|NEXGEL Inc - Rasio utang jangka cendhak marang modal|Retractable Technologies, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal HBIO (Harvard Bioscience Inc.)|FEMY - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal MeihuaMed MHUA|POAI (predictive-oncology.com) - Rasio utang jangka cendhak marang ekuitas|Callan JMB (CJMB) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ATRI|NURO (neurometrix.com) - Rasio silihan jangka cendhak marang modal